Experienced in Tetanus

Edison R. Alberto

Bacoor, PH 
Experienced in Tetanus
Bacoor, PH 
OverviewLocationsClinical Research

Overview

Edison Alberto practices in Bacoor, Philippines. Mr. Alberto is rated as an Experienced expert by MediFind in the treatment of Tetanus. His top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Tetanus, and Japanese Encephalitis.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Tetanus.

Gender
Male

Locations

Bacoor, Philippines
Other Locations
Imus, Philippines
Cavite City, Philippines
Makati City, Philippines
Manila, Philippines
Muntinlupa, Philippines

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Double-blind, Randomized, Controlled, Phase 2/3 Study to Evaluate the Efficacy, Immunogenicity, and Safety of CpG 1018/Alum-Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (SCB-2019) for the Prevention of SARS-CoV-2- Mediated COVID-19 in Participants Aged 12 Years and Older
A Double-blind, Randomized, Controlled, Phase 2/3 Study to Evaluate the Efficacy, Immunogenicity, and Safety of CpG 1018/Alum-Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (SCB-2019) for the Prevention of SARS-CoV-2- Mediated COVID-19 in Participants Aged 12 Years and Older
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Phase III, Multicenter, Observer Blind, Randomized, Controlled Study to Evaluate Immune Equivalence of Multi-dose Formulation Against Single-dose Formulation of Vi-DT Typhoid Conjugate Vaccine and Safety in Healthy Filipino......
A Phase III, Multicenter, Observer Blind, Randomized, Controlled Study to Evaluate Immune Equivalence of Multi-dose Formulation Against Single-dose Formulation of Vi-DT Typhoid Conjugate Vaccine and Safety in Healthy Filipino......
Enrollment Status: Completed
Publish Date: August 27, 2021
Intervention Type: Biological
Study Drugs: Vi-DT (Multi-dose formulation), Vi-DT (Single dose formulation), Control Vaccine
Study Phase: Phase 3
View 1 Less Clinical Trial

15 Total Publications

Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.
Journal: EClinicalMedicine
Published: December 21, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Alberto's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile